Related Experiment Videos
Clostridium difficile-associated diarrhea in adults
Susan M Poutanen1, Andrew E Simor
1Department of Microbiology, Toronto Medical Laboratories and Mount Sinai Hospital.
Summary
Clostridium difficile infection causes nosocomial diarrhea in adults, ranging from mild to severe colitis. Diagnosis involves detecting C. difficile toxins, with metronidazole as the primary treatment.
Area of Science:
- Infectious Diseases
- Gastroenterology
- Microbiology
Background:
- Clostridium difficile is a leading cause of hospital-acquired diarrhea in adults.
- Disease severity spans from mild diarrhea to life-threatening colitis.
- Pathogenesis involves disruption of gut flora and exposure to toxigenic C. difficile strains.
Purpose of the Study:
- To summarize the key aspects of Clostridium difficile infection, including its pathogenesis, diagnosis, and treatment.
- To provide an overview of current clinical management strategies for C. difficile-associated diarrhea.
Main Methods:
- Review of existing literature on Clostridium difficile infection.
- Analysis of diagnostic approaches for C. difficile toxins.
- Evaluation of therapeutic guidelines for C. difficile treatment.
Main Results:
- Diagnosis relies on detecting C. difficile toxins A or B.
- Oral metronidazole is the recommended first-line therapy.
- Oral vancomycin is reserved for specific patient groups or treatment failures.
Conclusions:
- Effective management of Clostridium difficile infection requires accurate diagnosis and appropriate therapeutic selection.
- Understanding the pathogenesis is crucial for preventing and treating this common nosocomial infection.
- Metronidazole and vancomycin are key pharmacologic agents in managing C. difficile-associated disease.